The principal biological processes of Icaritin’s anti-HCC targets involve protein phosphorylation, peptidyl-tyrosine phosphorylation, steroid metabolism, autophosphorylation of proteins, and positive regulation of the protein kinase B signaling pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.